Mumbai: DocExa, an exclusive digital platform developed using artificial intelligence (AI) technology to help doctors efficiently manage their patients and other engagements, was launched recently during DigiPharmaX (Digital Pharma Excellence) Awards 2017 at Mumbai.
As per the GlobalSpace Technologies, the developer of the DocExa, it leverages artificial intelligence, cloud and mobility technology to empower doctor, patients and pharma companies for meaningful and transparent engagement. It helps create a transparent engagement between the doctor and pharmaceutical communities while adhering to the government regulations and guidelines like Uniform Code of Pharma Marketing Practices (UCPMP), claims the company.
Additionally, doctors can file ADR through DocExa which provides real-time access of adverse drug reactions reports to Pharmaceutical companies and helps them to improve the quality of drugs. Doctors can also avail medico-legal consulting from a team of trusted, verified and reputed Legal Advisors, with the help of just a click or a tap.
Built on latest AI algorithms, the app is cross-platform and can be accessed through a smart- phone or a tab at any time and pace.